Merck & Co., Inc. Earnings Date, Estimates, & History

+0.04 (+0.06 %)
(As of 09/21/2021 04:00 PM ET)
Today's Range
50-Day Range
52-Week Range
Volume12.00 million shs
Average Volume11.46 million shs
Market Capitalization$182.18 billion
P/E Ratio32.86
Dividend Yield3.61%

Earnings Summary

Earnings Date
Oct. 28

Actual EPS
(Jul. 28)

Consensus EPS
(Jul. 28)

Last Year's Q3 EPS

Merck & Co., Inc. Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Merck & Co., Inc. Estimated Revenue and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Merck & Co., Inc. (NYSE:MRK) Earnings Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20211$1.63$1.63$1.63 
Q2 20212$1.40$1.94$1.67 
Q3 20212$1.50$1.59$1.55 
Q4 20212$1.42$1.57$1.50 
FY 20217$5.95$6.73$6.34

MRK Earnings Information

Merck & Co., Inc. last released its earnings data on July 28th, 2021. The reported $1.31 earnings per share for the quarter, meeting analysts' consensus estimates of $1.31. The company had revenue of $11.40 billion for the quarter, compared to analysts' expectations of $11.21 billion. Merck & Co., Inc. has generated $5.94 earnings per share over the last year ($2.19 diluted earnings per share) and currently has a price-to-earnings ratio of 32.9. Earnings for Merck & Co., Inc. are expected to grow by 13.97% in the coming year, from $5.51 to $6.28 per share. Merck & Co., Inc. has confirmed that its next quarterly earnings report will be published on Thursday, October 28th, 2021. Merck & Co., Inc. will be holding an earnings conference call on Thursday, October 28th at 8:00 AM Eastern. Interested parties can register for or listen to the call..

Merck & Co., Inc. (NYSE:MRK) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueActions
7/28/20216/30/2021$1.31$1.31$2.01$11.21 billion$11.40 billion    
4/29/20213/31/2021$1.63$1.40($0.23)$1.55$12.71 billion$12.08 billion  
2/3/202112/31/2020$1.38$1.32($0.06)$3.47$12.65 billion$12.51 billion  
10/27/20209/30/2020$1.44$1.74+$0.30$2.32$12.21 billion$12.55 billion  
7/31/20206/30/2020$1.14$1.37+$0.23$1.56$10.52 billion$10.87 billion    
4/28/20203/31/2020$1.34$1.50+$0.16$1.74$11.46 billion$12.06 billion  
2/5/202012/31/2019$1.15$1.16+$0.01$1.40$11.71 billion$11.87 billion  
10/29/20199/30/2019$1.24$1.51+$0.27$2.28$11.59 billion$12.40 billion  
7/30/20196/30/2019$1.16$1.30+$0.14$1.57$10.94 billion$11.76 billion
4/30/20193/31/2019$1.05$1.22+$0.17$1.32$10.45 billion$10.82 billion
2/1/201912/31/2018$1.03$1.04+$0.01$1.39$10.93 billion$11.00 billion  
10/25/20189/30/2018$1.14$1.19+$0.05$1.65$10.87 billion$10.79 billion
7/27/2018Q2 2018$1.0310$1.06+$0.0290$1.49$10.28 billion$10.47 billion
5/1/2018Q1 2018$0.9980$1.05+$0.0520$1.83$10.09 billion$10.04 billion
2/2/2018Q4 2017$0.94$0.98+$0.04$2.28$10.48 billion$10.43 billion  
10/27/2017Q3 2017$1.03$1.11+$0.08$2.24$10.54 billion$10.33 billion
7/28/2017Q2 17$0.87$1.01+$0.14$1.31$9.75 billion$9.93 billion
5/2/2017Q1 2017$0.83$0.88+$0.05$1.20$9.25 billion$9.43 billion  
2/2/2017Q416$0.8890$0.89+$0.0010$1.36$10.22 billion$10.10 billion  
10/25/2016Q316$0.99$1.07+$0.08$1.36$10.17 billion$10.50 billion  
7/29/2016Q216$0.91$0.93+$0.02$1.43$9.79 billion$9.84 billion  
5/5/2016Q116$0.85$0.89+$0.04$1.38$9.45 billion$9.30 billion
2/3/2016Q415$0.91$0.93+$0.02$1.51$10.32 billion$10.22 billion  
10/27/2015Q315$0.91$0.96+$0.05$1.28$10.11 billion$10.10 billion  
7/28/2015Q215$0.80$0.86+$0.06$1.48$9.81 billion$9.80 billion  
4/28/2015Q115$0.75$0.85+$0.10$1.37$9.04 billion$9.40 billion  
2/4/2015Q414$0.85$0.87+$0.02($0.80)$10.61 billion$10.48 billion  
10/27/2014Q314$0.88$0.90+$0.02$1.49$10.66 billion$10.56 billion  
7/29/2014Q214$0.81$0.85+$0.04$1.02$10.60 billion$10.93 billion  
4/29/2014Q114$0.79$0.88+$0.09$1.19$10.44 billion$10.30 billion  
2/5/2014Q4 2013$0.89$0.88($0.01)$1.50$11.39 billion$11.30 billion  
10/28/2013Q3 2013$0.88$0.92+$0.04$1.46$11.19 billion$11.03 billion  
7/30/2013Q2 2013$0.82$0.84+$0.02$1.38$11.22 billion$11.01 billion  
5/1/2013Q1 2013$0.78$0.85+$0.07$1.18$11.09 million$10.70 million  
2/1/2013Q4 2012$0.81$0.83+$0.02$11.46 billion$11.70 billion  
10/26/2012Q312$0.92$0.95+$0.03$11.60 billion$11.50 billion
10/29/2010Q3 2010$0.83$0.85+$0.02$1.59
7/30/2010Q2 2010$0.82$0.86+$0.04$1.48
5/4/2010Q1 2010$0.75$0.84+$0.09$1.58
2/16/2010Q4 2009$0.78$0.80+$0.02($0.76)
10/22/2009Q3 2009$0.82$0.90+$0.08$0.19
7/21/2009Q2 2009$0.78$0.83+$0.05$0.92
4/21/2009Q1 2009$0.77$0.74($0.03)$0.81
2/3/2009Q4 2008$0.74$0.87+$0.13$0.96
10/22/2008Q3 2008$0.79$0.80+$0.01$1.09
7/21/2008Q2 2008$0.83$0.86+$0.03$0.90
4/21/2008Q1 2008$0.85$0.89+$0.04$0.26
1/30/2008Q4 2007$0.73$0.80+$0.07$2.35
(Earnings results data provided by Zacks Investment Research)
speech bubbles
speech bubbles

Merck & Co., Inc. (NYSE:MRK) Earnings Frequently Asked Questions

When is Merck & Co., Inc.'s earnings date?

Merck & Co., Inc. has confirmed that its next quarterly earnings data will be published on Thursday, October 28th, 2021. Learn more on MRK's earnings history

Did Merck & Co., Inc. beat their earnings estimates last quarter?

In the previous quarter, Merck & Co., Inc. (NYSE:MRK) reported $1.31 earnings per share (EPS) to hit the analysts' consensus estimate of $1.31. Learn more on MRK's earnings details

How can I listen to Merck & Co., Inc.'s earnings conference call?

The conference call for Merck & Co., Inc.'s latest earnings report can be listened to online. Listen to Conference Call

How can I read Merck & Co., Inc.'s conference call transcript?

The conference call transcript for Merck & Co., Inc.'s latest earnings report can be read online. Read Transcript

How much revenue does Merck & Co., Inc. generate each year?

Merck & Co., Inc. (NYSE:MRK) has a recorded annual revenue of $47.99 billion.

How much profit does Merck & Co., Inc. generate each year?

Merck & Co., Inc. (NYSE:MRK) has a recorded net income of $7.07 billion. MRK has generated $5.94 earnings per share over the last four quarters.

What is Merck & Co., Inc.'s price-to-earnings ratio?

Merck & Co., Inc. (NYSE:MRK) has a trailing price-to-earnings ratio of 32.86 and a forward price-to-earnings ratio of 13.06. The price/earnings-to-growth ratio is 2.16.

What is Merck & Co., Inc.'s EPS forecast for next year?

Merck & Co., Inc.'s earnings are expected to grow from $5.51 per share to $6.28 per share in the next year, which is a 13.97% increase.

This page was last updated on 9/22/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.